Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BioMarin Prices Share Offering - Analyst Blog
NASDAQ
Sunday, June 3, 2012 - 12:24pm
tags:
Biomarin
Bristol, AstraZeneca among Amylin bidders-sources
Interactive Investor
Sunday, June 3, 2012 - 12:23pm
tags:
Bristol-Myers Squibb, AstraZeneca, Amylin, M&A
RSI Alert For Top-Ranked Teva Pharmaceutical Industries
Forbes
Sunday, June 3, 2012 - 12:21pm
tags:
Teva Pharmaceuticals
Teva chairman buys 1 mln shares of drugmaker
Reuters
Sunday, June 3, 2012 - 11:40am
tags:
Teva Pharmaceuticals
Actos again tied to bladder cancer risk
FiercePharma
Sunday, June 3, 2012 - 11:39am
tags:
Actos, bladder cancer, Takeda
€224 million EU antibiotics initiative launched
RSC
Sunday, June 3, 2012 - 11:38am
tags:
antibiotics
Aeolus Pharmaceuticals Announces AEOL 10150 Reduces Lung Damage After Neupogen(R) Treatment Following Radiation Exposure
equities.com
Sunday, June 3, 2012 - 11:37am
tags:
Aeolus Pharmaceuticals, AEOL 10150
Forest Laboratories and Nabriva sign development agreement for anti-bacterial drug
Proactive Investors
Sunday, June 3, 2012 - 11:34am
tags:
Nabriva Therapeutics, Forest Labs, BC-3781, antibiotics
Study: Hormone pill slows prostate cancer's growth
Yahoo/AP
Sunday, June 3, 2012 - 11:19am
tags:
Zytiga, JNJ, prostate cancer
Bristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study
Bloomberg
Sunday, June 3, 2012 - 11:17am
tags:
skin cancer, Bristol-Myers Squibb, BMS-936558, kidney cancer, lung cancer
Human Genome Sciences: Poison Pills Can Kill You If Your Suitor Walks Away
Seeking Alpha
Sunday, June 3, 2012 - 11:15am
tags:
Human Genome Sciences
3 Biotech Stocks Outperforming On Insider, Hedge Fund Buying
Seeking Alpha
Sunday, June 3, 2012 - 11:14am
tags:
Theravance, Repros Therapeutics, Ziopharm
Study: 'Smart bomb' drug attacks breast cancer
Yahoo/AP
Sunday, June 3, 2012 - 11:13am
tags:
T-DM1, breast cancer, Genentech, Roche
Results from a Randomized Study of REVLIMID® (Lenalidomide) and Rituximab (R2) in Patients with Recurrent Follicular Lymphoma Presented at ASCO
Yahoo/Business Wire
Sunday, June 3, 2012 - 11:10am
tags:
Revlimid, rituximab, follicular lymphoma, Cellgene
Cabozantinib Demonstrates Encouraging Activity in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma
Yahoo/Business Wire
Sunday, June 3, 2012 - 11:09am
tags:
cabozantinib, renal cell carcinoma, Exelixis
The Market Is Wrong About Vertex
Motley Fool
Sunday, June 3, 2012 - 11:08am
tags:
Vertex Pharmaceuticals
Puma Biotechnology presents positive PB272 clinical data at ASCO
Yahoo/The Fly On The Wall
Sunday, June 3, 2012 - 11:07am
tags:
Puma Biotechnology, PB272, breast cancer
Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting
Yahoo/PR NewsWire
Sunday, June 3, 2012 - 11:06am
tags:
PX-866, Oncothyreon, non-small cell lung cancer, squamous cell cancer
Reliv Announces Breakthrough in Fight Against Metabolic Syndrome
Yahoo/PR NewsWire
Sunday, June 3, 2012 - 11:02am
tags:
Reliv, metabolic syndrome, GlucAffect, LunaRich
Bristol CEO says Gilead holding out on hep C tie-up
Fierce Biotech
Friday, June 1, 2012 - 12:30pm
tags:
Bristol-Myers Squibb, Gilead, hepatitis C, Lamberto Andreotti, daclatasvir, GS-7977

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.